Approval · Notice of Compliance 3621 · 2003
VIREAD: Notice of Compliance 3621
Issued March 18, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 3621
- Date
- March 18, 2003
- Company
- Gilead Sciences, Inc.Foster City, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antiretroviral agent
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIREAD | 02247128 | Marketed |
Medicinal ingredients
- TENOFOVIR DISOPROXIL FUMARATE 300 MG per TAB